Our findings using genetic blockade of GLI transcription factors identify a strict requirement for HH- responsiveness in epithelial cell populations of taste papillae during taste organ homeostasis, and uncover the likely mechanism underlying taste loss in cancer patients treated with systemic HH pathway inhibitors [29,30]. Here, GLI1 is linked to cancer.